ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
PP&E Gross
ADC Therapeutics SA
PP&E Gross Peer Comparison
Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Gross | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
PP&E Gross
CHf6.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
PP&E Gross
$305.9m
|
CAGR 3-Years
49%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
PP&E Gross
CHf20.6m
|
CAGR 3-Years
57%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
PP&E Gross
CHf245.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
PP&E Gross
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|